Prophase Labs

Prophase Labs OCF/Debt

The Operating Cash Flow to Debt Ratio of Prophase Labs (PRPH) as of Nov 15, 2026 is -96.82 %. In the previous year, Operating Cash Flow to Debt Ratio was -71.37 % — a change of 35.66% (lower).

OCF/Debt

-96.82 %

YoY

35.66%

Last updated:

Operating Cash Flow to Debt Ratio of Prophase Labs is 2025 -96.82 % . Operating Cash Flow to Debt Ratio of Prophase Labs was 2024 -71.37 % . It decreases by 35.66% lower compared to the previous year.

The Prophase Labs OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2018
-59.01 USD
Jan 1, 2019
-90.82 USD
Jan 1, 2020
-17.61 USD
Jan 1, 2021
-91.40 USD
Jan 1, 2022
410.22 USD
Jan 1, 2023
-61.49 USD
Jan 1, 2024
-71.37 USD
Jan 1, 2025
-96.82 USD
The Prophase Labs OCF/Debt history
YEAROCF/DebtYoY
-96.82 %+35.66%
-71.37 %+16.08%
-61.49 %-114.99%
410.22 %-548.83%
-91.40 %+419.11%
-17.61 %-80.61%
-90.82 %+53.91%
-59.01 %+86.28%
-31.68 %-86.72%
-238.54 %-92.58%
-3,216.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Prophase Labs Stock analysis

What does Prophase Labs do? ProPhase Labs, Inc. generates revenue through the sale of over-the-counter consumer healthcare products and dietary supplements. The company develops and markets TK Supplements, featuring LEGENDZ XL for male sexual enhancement, TRIPLE EDGE XL for daily energy and stamina, and SUPER PROSTAFLOW plus for prostate and urinary health. ORXx Complete, a dietary supplement, and ORXx cough/cold drops are also sold to national wholesalers, distributors, and retail chains including pharmacies and mass merchandise stores. The firm targets health-conscious consumers seeking natural solutions through its OTC drug and supplement lines. Its products are distributed via national wholesalers and retailers such as independent and chain drugstores, food stores, and mass merchandise outlets. ProPhase Labs focuses on direct sales to these established retail segments without third-party branding or partnerships. Revenue streams are derived from the consistent demand for male enhancement, energy, and health supplements within the OTC market. The company's product portfolio caters specifically to customers interested in natural health products, with no additional services or digital platforms beyond physical product sales. Prophase Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Prophase Labs stock

Operating Cash Flow to Debt Ratio of Prophase Labs is -96.82 % in 2025.

Operating Cash Flow to Debt Ratio of Prophase Labs changed from -71.37 % to -96.82 %, representing a 35.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Prophase Labs since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Prophase Labs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Prophase Labs

All Key Metrics — Prophase Labs